Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.55 - May 2018 - Special section: Sexualised drug use
Auteur(s) :
DESAI, M. (Éditeur scientifique) ;
BOURNE, A. (Éditeur scientifique) ;
HOPE, V. (Éditeur scientifique) ;
HALKITIS, P. N. (Éditeur scientifique)
Paru le :
01/05/2018
Année
2018
Page(s) :
1-262
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Improving drug policy: The potential of broader democratic participation. Ritter A., Lancaster K., Diprose R., p. 1-7.
- Pharmaceutical opioid overdose deaths and the presence of witnesses. Ogeil R.P., Dwyer J., Bugeja L., Heilbronn C., Lubman D.I., Lloyd B., p. 8-13.
- An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation. Overbye M., p. 14-30.
- Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. Janjua N.Z., Islam N., Kuo M., Yu A., Wong S., Butt Z.A., et al., p. 31-39.
- The perspectives of structurally vulnerable people who use drugs on volunteer stipends and work experiences provided through a drug user organization: Opportunities and limitations. Bardwell G., Anderson S., Richardson L., Bird L., Lampkin H., Small W., et al., p. 40-46.
- "Blood letting" - Self-phlebotomy in injecting anabolic-androgenic steroids within performance and image enhancing drug (PIED) culture. Brennan R., Wells J., Van Hout M.C., p. 47-50.
- A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Guise A., Melo J., Mittal M.L., Rafful C., Cuevas-Mota J., Davidson P., et al., p. 51-60.
- Effects of naloxone distribution to likely bystanders: Results of an agent-based model. Keane C., Egan J.E., Hawk M., p. 61-69.
- A qualitative examination of the effects of international counter-drug interdictions. Toth A.G., Mitchell O., p. 70-76.
- Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis. Collins A.B., Bluthenthal R.N., Boyd J., McNeil R., p. 77-79.
- Heroic journeys through sobriety: How temporary alcohol abstinence campaigns portray participant experiences. Bartram A., Hanson-Easey S., Eliott J., p. 80-87.
- A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand. Rychert M., Wilkins C., p. 88-94.
- Federal funding for syringe exchange in the US: Explaining a long-term policy failure. Showalter D., p. 95-104.
- Identifying a typology of men who use anabolic androgenic steroids (AAS). Zahnow R., McVeigh J., Bates G., Hope V., Kean J., Campbell J., et al., p. 105-112.
- Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: A 24-month retrospective analysis of a nationally representative sample. Hoang T., Nguyen H., Shiraishi R.W., Nguyen M., Bingham T., Nguyen D., et al., p. 113-120.
- Ageing opioid users' increased risk of methadone-specific death in the UK. Pierce M., Millar T., Robertson J.R., Bird S.M., p. 121-127.
SPECIAL SECTION "Sexualised drug use"
- Sexualised drug use: LGTB communities and beyond. Desai M., Bourne A., Hope V., Halkitis P.N., p. 128-130.
- Sexualised drug use in the United Kingdom (UK): A review of the literature. Edmundson C., Heinsbroek E., Glass R., Hope V., Mohammed H., White M., et al., p. 131-148.
- Surveillance of sexualised drug use - the challenges and the opportunities. Giraudon I., Schmidt A.J., Mohammed H., p. 149-154.
- Demand for and availability of specialist chemsex services in the UK: A cross-sectional survey of sexual health clinics. Wiggins H., Ogaz D., Mebrahtu H., Sullivan A., Bowden-Jones O., Field N., et al., p. 155-158.
- Typology of drug use in United Kingdom men who have sex with men and associations with socio-sexual characteristics. Melendez-Torres G.J., Bourne A., Reid D., Hickson F., Bonell C., Weatherburn P., p. 159-164.
- Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies. Ezard N., Webb B., Clifford B., Cecilio M.E., Jellie A., Lea T., et al., p. 165-168.
- Mental health, drug use and sexual risk behavior among gay and bisexual men. Prestage G., Hammoud M., Jin F., Degenhardt L., Bourne A., Maher L., p. 169-179.
- Chemsex and mental health as part of syndemic in gay and bisexual men. Halkitis P.N., Singer S.N., p. 180-182.
- Implications of survey labels and categorisations for understanding drug use in the context of sex among gay and bisexual men in Melbourne, Australia. Ryan K.E., Wilkinson A.L., Pedrana A., Quinn B., Dietze P., Hellard M., et al., p. 183-186.
- Problematising LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia. Pienaar K., Murphy D.A., Race K., Lea T., p. 187-194.
- A response to Pienaar et al (2018) 'Problematizing LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia'. Ruth S., Parkhill N., Reynolds R., p. 195-196.
- The new MTV generation: Using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe. Hammoud M.A., Vaccher S., Jin F., Bourne A., Haire B., Maher L., et al., p. 197-204.
- Response to the Hammoud et al paper on 'the new MTV generation'. Gafos M., Chas J., Pialoux G., p. 205-206.
- Sexualised drug use among sexual minority young adults in the United States: The P18 cohort study. Ristuccia A., LoSchiavo C., Halkitis P.N., Kapadia F., p. 207-214.
- Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016. Heinsbroek E., Glass R., Edmundson C., Hope V., Desai M., p. 215-221.
- Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study. Bui H., Zablotska-Manos I., Hammoud M., Jin F., Lea T., Bourne A., et al., p. 222-230.
- Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey. Rosinska M., Gios L., Nöstlinger C., Vanden Berghe W., Marcus U., Schink S., et al., p. 231-241.
- The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. Bryant J., Hopwood M., Dowsett G.W., Aggleton P., Holt M., Lea T., et al., p. 242-248.
- Ice parties among young men who have sex with men in Thailand: Pleasures, secrecy and risks. Guadamuz T.E., Boonmongkon P., p. 249-255.
- The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Lim S.H., Akbar M., Wickersham J.A., Kamarulzaman A., Altice F.L., p. 256-262.
- Improving drug policy: The potential of broader democratic participation. Ritter A., Lancaster K., Diprose R., p. 1-7.
- Pharmaceutical opioid overdose deaths and the presence of witnesses. Ogeil R.P., Dwyer J., Bugeja L., Heilbronn C., Lubman D.I., Lloyd B., p. 8-13.
- An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation. Overbye M., p. 14-30.
- Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. Janjua N.Z., Islam N., Kuo M., Yu A., Wong S., Butt Z.A., et al., p. 31-39.
- The perspectives of structurally vulnerable people who use drugs on volunteer stipends and work experiences provided through a drug user organization: Opportunities and limitations. Bardwell G., Anderson S., Richardson L., Bird L., Lampkin H., Small W., et al., p. 40-46.
- "Blood letting" - Self-phlebotomy in injecting anabolic-androgenic steroids within performance and image enhancing drug (PIED) culture. Brennan R., Wells J., Van Hout M.C., p. 47-50.
- A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Guise A., Melo J., Mittal M.L., Rafful C., Cuevas-Mota J., Davidson P., et al., p. 51-60.
- Effects of naloxone distribution to likely bystanders: Results of an agent-based model. Keane C., Egan J.E., Hawk M., p. 61-69.
- A qualitative examination of the effects of international counter-drug interdictions. Toth A.G., Mitchell O., p. 70-76.
- Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis. Collins A.B., Bluthenthal R.N., Boyd J., McNeil R., p. 77-79.
- Heroic journeys through sobriety: How temporary alcohol abstinence campaigns portray participant experiences. Bartram A., Hanson-Easey S., Eliott J., p. 80-87.
- A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand. Rychert M., Wilkins C., p. 88-94.
- Federal funding for syringe exchange in the US: Explaining a long-term policy failure. Showalter D., p. 95-104.
- Identifying a typology of men who use anabolic androgenic steroids (AAS). Zahnow R., McVeigh J., Bates G., Hope V., Kean J., Campbell J., et al., p. 105-112.
- Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: A 24-month retrospective analysis of a nationally representative sample. Hoang T., Nguyen H., Shiraishi R.W., Nguyen M., Bingham T., Nguyen D., et al., p. 113-120.
- Ageing opioid users' increased risk of methadone-specific death in the UK. Pierce M., Millar T., Robertson J.R., Bird S.M., p. 121-127.
SPECIAL SECTION "Sexualised drug use"
- Sexualised drug use: LGTB communities and beyond. Desai M., Bourne A., Hope V., Halkitis P.N., p. 128-130.
- Sexualised drug use in the United Kingdom (UK): A review of the literature. Edmundson C., Heinsbroek E., Glass R., Hope V., Mohammed H., White M., et al., p. 131-148.
- Surveillance of sexualised drug use - the challenges and the opportunities. Giraudon I., Schmidt A.J., Mohammed H., p. 149-154.
- Demand for and availability of specialist chemsex services in the UK: A cross-sectional survey of sexual health clinics. Wiggins H., Ogaz D., Mebrahtu H., Sullivan A., Bowden-Jones O., Field N., et al., p. 155-158.
- Typology of drug use in United Kingdom men who have sex with men and associations with socio-sexual characteristics. Melendez-Torres G.J., Bourne A., Reid D., Hickson F., Bonell C., Weatherburn P., p. 159-164.
- Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies. Ezard N., Webb B., Clifford B., Cecilio M.E., Jellie A., Lea T., et al., p. 165-168.
- Mental health, drug use and sexual risk behavior among gay and bisexual men. Prestage G., Hammoud M., Jin F., Degenhardt L., Bourne A., Maher L., p. 169-179.
- Chemsex and mental health as part of syndemic in gay and bisexual men. Halkitis P.N., Singer S.N., p. 180-182.
- Implications of survey labels and categorisations for understanding drug use in the context of sex among gay and bisexual men in Melbourne, Australia. Ryan K.E., Wilkinson A.L., Pedrana A., Quinn B., Dietze P., Hellard M., et al., p. 183-186.
- Problematising LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia. Pienaar K., Murphy D.A., Race K., Lea T., p. 187-194.
- A response to Pienaar et al (2018) 'Problematizing LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia'. Ruth S., Parkhill N., Reynolds R., p. 195-196.
- The new MTV generation: Using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe. Hammoud M.A., Vaccher S., Jin F., Bourne A., Haire B., Maher L., et al., p. 197-204.
- Response to the Hammoud et al paper on 'the new MTV generation'. Gafos M., Chas J., Pialoux G., p. 205-206.
- Sexualised drug use among sexual minority young adults in the United States: The P18 cohort study. Ristuccia A., LoSchiavo C., Halkitis P.N., Kapadia F., p. 207-214.
- Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016. Heinsbroek E., Glass R., Edmundson C., Hope V., Desai M., p. 215-221.
- Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study. Bui H., Zablotska-Manos I., Hammoud M., Jin F., Lea T., Bourne A., et al., p. 222-230.
- Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey. Rosinska M., Gios L., Nöstlinger C., Vanden Berghe W., Marcus U., Schink S., et al., p. 231-241.
- The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. Bryant J., Hopwood M., Dowsett G.W., Aggleton P., Holt M., Lea T., et al., p. 242-248.
- Ice parties among young men who have sex with men in Thailand: Pleasures, secrecy and risks. Guadamuz T.E., Boonmongkon P., p. 249-255.
- The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Lim S.H., Akbar M., Wickersham J.A., Kamarulzaman A., Altice F.L., p. 256-262.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
N. Z. JANJUA ;
N. ISLAM ;
M. KUO ;
A. YU ;
S. WONG ;
Z. A. BUTT ;
M. GILBERT ;
J. BUXTON ;
N. CHAPINAL ;
H. SAMJI ;
M. CHONG ;
M. ALVAREZ ;
J. WONG ;
M. W. TYNDALL ;
M. KRAJDEN
|
2018
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Background: Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiat[...]
C. EDMUNDSON ;
E. HEINSBROEK ;
R. GLASS ;
V. HOPE ;
H. MOHAMMED ;
M. WHITE ;
M. DESAI
|
2018
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Background: Sexualised drug use (SDU) refers to the use of drugs in a sexual context. This includes 'Chemsex'- the use of drugs (specifically crystal methamphetamine, GHB/GBL and mephedrone) before or during planned sexual activity to sustain, e[...]
I. GIRAUDON ;
A. J. SCHMIDT ;
H. MOHAMMED
|
2018
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.55, May 2018) Article : Périodique
Sexualised drug use (SDU), the use of drugs in a sexual context, has emerged as a marker of high-risk sexual activity and poor sexual health among gay, bisexual and other men who have sex with men, however, there are no robust estimates of the p[...]